These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28165246)

  • 41. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of binding capability of targeted KDR ultrasound contrast agent in vitro for evaluating endometrial receptivity].
    Liu H; Han X; Yang L; Ji L; Li S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1308-11. PubMed ID: 24067209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and characterization of targeted ultrasound microbubbles for diagnostic use.
    Myrset AH; Fjerdingstad HB; Bendiksen R; Arbo BE; Bjerke RM; Johansen JH; Kulseth MA; Skurtveit R
    Ultrasound Med Biol; 2011 Jan; 37(1):136-50. PubMed ID: 21144962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents.
    Stieger SM; Dayton PA; Borden MA; Caskey CF; Griffey SM; Wisner ER; Ferrara KW
    Contrast Media Mol Imaging; 2008; 3(1):9-18. PubMed ID: 18335479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
    La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
    J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis.
    Pillai R; Marinelli ER; Fan H; Nanjappan P; Song B; von Wronski MA; Cherkaoui S; Tardy I; Pochon S; Schneider M; Nunn AD; Swenson RE
    Bioconjug Chem; 2010 Mar; 21(3):556-62. PubMed ID: 20170116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasound Molecular Imaging of Atherosclerosis for Early Diagnosis and Therapeutic Evaluation through Leucocyte-like Multiple Targeted Microbubbles.
    Yan F; Sun Y; Mao Y; Wu M; Deng Z; Li S; Liu X; Xue L; Zheng H
    Theranostics; 2018; 8(7):1879-1891. PubMed ID: 29556362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
    Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
    Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
    Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
    Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
    Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles.
    Xie A; Belcik T; Qi Y; Morgan TK; Champaneri SA; Taylor S; Davidson BP; Zhao Y; Klibanov AL; Kuliszewski MA; Leong-Poi H; Ammi A; Lindner JR
    JACC Cardiovasc Imaging; 2012 Dec; 5(12):1253-62. PubMed ID: 23236976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model.
    Chan ES; Patel AR; Larchian WA; Heston WD
    J Urol; 2011 Jun; 185(6):2359-65. PubMed ID: 21511281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
    Unnikrishnan S; Klibanov AL
    AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy.
    Rojas JD; Lin F; Chiang YC; Chytil A; Chong DC; Bautch VL; Rathmell WK; Dayton PA
    Theranostics; 2018; 8(1):141-155. PubMed ID: 29290798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Mancini M; Greco A; Salvatore G; Liuzzi R; Di Maro G; Vergara E; Chiappetta G; Pasquinelli R; Brunetti A; Salvatore M
    BMC Med Imaging; 2013 Sep; 13():31. PubMed ID: 24028408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.